Monthly Archives: January 2008

Edetate Disodium

The FDA have issued warnings about the potential confusion between edetate disodium instead of edetate calcium disodium, and the unlicenced use of edetate disodium for chelation therapy. There have been cases where children and adults have died when they were … Continue reading

Posted in FDA | Comments Off

Drug Safety Update January 2008

The MHRA have published the January edition of Drug Safety Update. This month’s edition contains: Statins: interactions, and updated advice for atorvastatin Methylthioninium chloride (methylene blue): CNS toxicity with serotonergic drugs Desmomelt (desmopressin): call for Yellow Card reporting Bivalirudin: risks … Continue reading

Posted in MHRA | Comments Off

Bisphosphonates and severe musculoskeletal pain

The FDA have issued advice about bisphosphonates and severe musculoskeletal pain. The severe musculoskeletal pain may occur within days, months, or years after starting a bisphosphonate. Some patients have reported complete relief of symptoms after discontinuing the bisphosphonate, whereas others … Continue reading

Posted in FDA | Comments Off

Happy New Year

The West Midlands Centre for Adverse Drug Reactions wishes all of our readers a Happy New Year. We hope you have a prosperous 2008, and don’t forget to report any adverse drug reactions you come across.

Posted in Yellow Card Scheme | Comments Off